BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen P, Li J, Jiang HG, Lan T, Chen YC. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway. Tumour Biol 2015;36:3591-9. [PMID: 25542235 DOI: 10.1007/s13277-014-2996-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Jelezova I, Drakalska E, Momekova D, Shalimova N, Momekov G, Konstantinov S, Rangelov S, Pispas S. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems. Eur J Pharm Sci 2015;78:67-78. [PMID: 26159739 DOI: 10.1016/j.ejps.2015.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
2 Li C, Ge X, Wang L. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Biomed Pharmacother 2017;86:628-36. [PMID: 28027539 DOI: 10.1016/j.biopha.2016.12.042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
3 Hanikoglu A, Kucuksayan E, Hanikoglu F, Ozben T, Menounou G, Sansone A, Chatgilialoglu C, Di Bella G, Ferreri C. Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes. Can J Physiol Pharmacol 2020;98:131-8. [PMID: 31545905 DOI: 10.1139/cjpp-2019-0352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Li S, Fang C, Zhang J, Liu B, Wei Z, Fan X, Sui Z, Tan Q. Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin. Nanomedicine 2016;12:1567-79. [PMID: 26995093 DOI: 10.1016/j.nano.2016.02.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
5 Batra H, Pawar S, Bahl D. Curcumin in combination with anti-cancer drugs: A nanomedicine review. Pharmacol Res 2019;139:91-105. [PMID: 30408575 DOI: 10.1016/j.phrs.2018.11.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
6 Chen P, Huang HP, Wang Y, Jin J, Long WG, Chen K, Zhao XH, Chen CG, Li J. Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death. J Exp Clin Cancer Res 2019;38:254. [PMID: 31196210 DOI: 10.1186/s13046-019-1234-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
7 Salehi M, Movahedpour A, Tayarani A, Shabaninejad Z, Pourhanifeh MH, Mortezapour E, Nickdasti A, Mottaghi R, Davoodabadi A, Khan H, Savardashtaki A, Mirzaei H. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma. Phytother Res 2020;34:2557-76. [PMID: 32307773 DOI: 10.1002/ptr.6704] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
8 Xu C, Wang M, Guo W, Sun W, Liu Y. Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy. Front Oncol 2021;11:672490. [PMID: 34094974 DOI: 10.3389/fonc.2021.672490] [Reference Citation Analysis]
9 Alì G, Bruno R, Poma AM, Affinito O, Monticelli A, Piaggi P, Ricciardi S, Lucchi M, Melfi F, Chella A, Cocozza S, Fontanini G. Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas. Sci Rep 2019;9:3536. [PMID: 30837581 DOI: 10.1038/s41598-019-40016-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Alam MN, Moni MA, Yu JQ, Beale P, Turner P, Proschogo N, Rahman MA, Hossain MP, Huq F. Promising Anticancer Activity of [Bis(1,8-quinolato)palladium (II)] Alone and in Combination. Int J Mol Sci 2021;22:8471. [PMID: 34445176 DOI: 10.3390/ijms22168471] [Reference Citation Analysis]
11 Haider T, Pandey V, Banjare N, Gupta PN, Soni V. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep 2020;72:1125-51. [PMID: 32700248 DOI: 10.1007/s43440-020-00138-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Somasundram B, Manogaran P, Vasudevan M, Viswanadha VP. Chemosensitizing effect of neferine on cisplatin-resistant colorectal cancer: Identification of potential candidate genes and pathways through whole transcriptome profiling. Phytomedicine Plus 2022;2:100299. [DOI: 10.1016/j.phyplu.2022.100299] [Reference Citation Analysis]
13 Sadoughi F, Maleki Dana P, Asemi Z, Yousefi B. Targeting microRNAs by curcumin: implication for cancer therapy. Crit Rev Food Sci Nutr 2021;:1-12. [PMID: 33905266 DOI: 10.1080/10408398.2021.1916876] [Reference Citation Analysis]
14 Majidinia M, Bishayee A, Yousefi B. Polyphenols: Major regulators of key components of DNA damage response in cancer. DNA Repair 2019;82:102679. [DOI: 10.1016/j.dnarep.2019.102679] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
15 Lagunas-Rangel FA, Bermúdez-Cruz RM. Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells. Front Oncol 2020;10:598174. [PMID: 33330091 DOI: 10.3389/fonc.2020.598174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Wei Y, Yang P, Cao S, Zhao L. The combination of curcumin and 5-fluorouracil in cancer therapy. Arch Pharm Res 2018;41:1-13. [PMID: 29230689 DOI: 10.1007/s12272-017-0979-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
17 Fan XZ, Chen YF, Zhang SB, He DH, Wei SF, Wang Q, Pan HF, Liu YQ. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway. Phytomedicine 2021;91:153689. [PMID: 34446320 DOI: 10.1016/j.phymed.2021.153689] [Reference Citation Analysis]
18 Jiang HG, Chen P, Su JY, Wu M, Qian H, Wang Y, Li J. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells. J Cell Physiol 2017;232:3433-43. [PMID: 28075014 DOI: 10.1002/jcp.25792] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
19 Guo S, Lv L, Shen Y, Hu Z, He Q, Chen X. A nanoparticulate pre-chemosensitizer for efficacious chemotherapy of multidrug resistant breast cancer. Sci Rep 2016;6:21459. [PMID: 26875787 DOI: 10.1038/srep21459] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
20 Vollono L, Falconi M, Gaziano R, Iacovelli F, Dika E, Terracciano C, Bianchi L, Campione E. Potential of Curcumin in Skin Disorders. Nutrients 2019;11:E2169. [PMID: 31509968 DOI: 10.3390/nu11092169] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
21 Huang W, Tang H, Wen F, Lu X, Li Q, Shu P. Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression. BMC Complement Med Ther 2020;20:196. [PMID: 32586310 DOI: 10.1186/s12906-020-02983-8] [Reference Citation Analysis]
22 Wang Z, Chen N, Yang J, Wang Q, Li A. Microarray gene profiling analysis of glioblastoma cell line U87 reveals suppression of the FANCD2/Fanconi anemia pathway by the combination of Y15 and temozolomide. Arch Med Sci 2019;15:1035-46. [PMID: 31360198 DOI: 10.5114/aoms.2019.86063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Huang WT, Larsson M, Lee YC, Liu DM, Chiou GY. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells. Eur J Pharm Biopharm 2016;109:165-73. [PMID: 27793756 DOI: 10.1016/j.ejpb.2016.10.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
24 Dai CH, Chen P, Li J, Lan T, Chen YC, Qian H, Chen K, Li MY. Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival. Oncotarget 2016;7:65157-70. [PMID: 27533083 DOI: 10.18632/oncotarget.11214] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
25 Thulasiraman P, Garriga G, Danthuluri V, McAndrews DJ, Mohiuddin IQ. Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells. Oncol Rep 2017;37:2007-15. [PMID: 28350049 DOI: 10.3892/or.2017.5495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
26 Tong YH, Zhang B, Fan Y, Lin NM. Keap1-Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics. Chronic Dis Transl Med 2015;1:175-86. [PMID: 29063005 DOI: 10.1016/j.cdtm.2015.09.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
27 Alarjah MA, Shahin MH, Al-azzah F, Alarjah AA, Omran ZH. Concomitant analysis of dasatinib and curcuminoids in a pluronic-based nanoparticle formulation using a novel HPLC method. Chromatographia 2020;83:1355-70. [DOI: 10.1007/s10337-020-03956-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Momtazi-borojeni AA, Mosafer J, Nikfar B, Ekhlasi-hundrieser M, Chaichian S, Mehdizadehkashi A, Vaezi A. Curcumin in Advancing Treatment for Gynecological Cancers with Developed Drug- and Radiotherapy-Associated Resistance. In: de Tombe P, Gudermann T, Jahn R, Lill R, editors. Reviews of Physiology, Biochemistry and Pharmacology 176. Cham: Springer International Publishing; 2019. pp. 107-29. [DOI: 10.1007/112_2018_11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Tchounwou PB, Dasari S, Noubissi FK, Ray P, Kumar S. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. J Exp Pharmacol 2021;13:303-28. [PMID: 33776489 DOI: 10.2147/JEP.S267383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
30 Ma Y, Wang X, Zong S, Zhang Z, Xie Z, Huang Y, Yue Y, Liu S, Jing X. Local, combination chemotherapy in prevention of cervical cancer recurrence after surgery by using nanofibers co-loaded with cisplatin and curcumin. RSC Adv 2015;5:106325-32. [DOI: 10.1039/c5ra17230f] [Cited by in Crossref: 20] [Article Influence: 2.9] [Reference Citation Analysis]
31 Bordoloi D, Kunnumakkara AB. The Potential of Curcumin: A Multitargeting Agent in Cancer Cell Chemosensitization. Role of Nutraceuticals in Chemoresistance to Cancer. Elsevier; 2018. pp. 31-60. [DOI: 10.1016/b978-0-12-812373-7.00002-4] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
32 Block KI. Integrative Cancer Therapies: Learning From COVID-19. Integr Cancer Ther 2020;19:1534735420932652. [PMID: 32567371 DOI: 10.1177/1534735420932652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Kundur S, Prayag A, Selvakumar P, Nguyen H, Mckee L, Cruz C, Srinivasan A, Shoyele S, Lakshmikuttyamma A. Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines. J Cell Physiol 2019;234:11103-18. [DOI: 10.1002/jcp.27761] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
34 Wang GZ, Liu YQ, Cheng X, Zhou GB. Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents. Cancer Sci 2015;106:902-8. [PMID: 25891850 DOI: 10.1111/cas.12679] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
35 Khan H, Labanca F, Ullah H, Hussain Y, Tzvetkov NT, Akkol EK, Milella L. Advances and challenges in cancer treatment and nutraceutical prevention: the possible role of dietary phenols in BRCA regulation. Phytochem Rev. [DOI: 10.1007/s11101-021-09771-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
36 Ben-arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, Schiff E, Charalambous H, Dweikat T, Ghrayeb I, Bar-sela G, Turker I, Hassan A, Hassan E, Saad B, Nimri O, Kebudi R, Silbermann M. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals: Risks Associated With Herbal Use. Cancer 2016;122:598-610. [DOI: 10.1002/cncr.29796] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
37 Wu J, Xiao S, Yuan M, Li Q, Xiao G, Wu W, Ouyang Y, Huang L, Yao C. PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis. Mol Med Rep 2019;19:75-84. [PMID: 30431088 DOI: 10.3892/mmr.2018.9628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Song Z, Wang H, Zhang S. Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency. Biomed Pharmacother 2019;118:109336. [PMID: 31545260 DOI: 10.1016/j.biopha.2019.109336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
39 Chen P, Li J, Chen YC, Qian H, Chen YJ, Su JY, Wu M, Lan T. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells. Cell Oncol (Dordr) 2016;39:511-22. [PMID: 27473273 DOI: 10.1007/s13402-016-0291-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
40 Lelli D, Sahebkar A, Johnston TP, Pedone C. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol Res 2017;115:133-48. [PMID: 27888157 DOI: 10.1016/j.phrs.2016.11.017] [Cited by in Crossref: 135] [Cited by in F6Publishing: 132] [Article Influence: 22.5] [Reference Citation Analysis]
41 Rezaee R, Momtazi AA, Monemi A, Sahebkar A. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacological Research 2017;117:218-27. [DOI: 10.1016/j.phrs.2016.12.037] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 20.0] [Reference Citation Analysis]
42 Zakaria N, Satar NA, Abu Halim NH, Ngalim SH, Yusoff NM, Lin J, Yahaya BH. Targeting Lung Cancer Stem Cells: Research and Clinical Impacts. Front Oncol 2017;7:80. [PMID: 28529925 DOI: 10.3389/fonc.2017.00080] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 12.0] [Reference Citation Analysis]
43 Rejinold NS, Yoo J, Jon S, Kim YC. Curcumin as a Novel Nanocarrier System for Doxorubicin Delivery to MDR Cancer Cells: In Vitro and In Vivo Evaluation. ACS Appl Mater Interfaces 2018;10:28458-70. [PMID: 30064206 DOI: 10.1021/acsami.8b10426] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
44 Negrette-Guzmán M. Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy. Eur J Pharmacol 2019;859:172513. [PMID: 31260654 DOI: 10.1016/j.ejphar.2019.172513] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
45 Wang H, Yang Z, Dai X, Chen Y, Yang H, Zhou X. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Apoptosis 2017;22:1157-68. [DOI: 10.1007/s10495-017-1395-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
46 Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, Raee P, Aghamiri S, Ashrafizadeh M, Aref AR, Hamblin MR, Hushmandi K, Zarrabi A, Sethi G. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res 2021. [PMID: 34697839 DOI: 10.1002/ptr.7305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wang L, Wang H, Wang T, Liu J, Chen W, Wang Y, Chen C, Zhu H, Dai P. Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms. Artif Cells Nanomed Biotechnol. 2019;47:1101-1112. [PMID: 30942098 DOI: 10.1080/21691401.2019.1575846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
48 Gao Y, Luo XD, Yang XL, Tu D. Clinical significance of breast cancer susceptibility gene 1 expression in resected non-small cell lung cancer: A meta-analysis . World J Clin Cases 2021; 9(30): 9090-9100 [PMID: 34786391 DOI: 10.12998/wjcc.v9.i30.9090] [Reference Citation Analysis]
49 Wang Q, Zhang L, Xiao Y, Ghaemnezhad A. Diosgenin promotes cisplatin‐induced apoptosis through oxidative DNA damage in A549 non‐small cell lung cells. Cell Biology International. [DOI: 10.1002/cbin.11862] [Reference Citation Analysis]
50 Ali-shtayeh MS, Jamous RM, Salameh NM, Jamous RM, Hamadeh AM. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns. Journal of Ethnopharmacology 2016;187:104-22. [DOI: 10.1016/j.jep.2016.04.038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
51 Wattanathamsan O, Hayakawa Y, Pongrakhananon V. Molecular mechanisms of natural compounds in cell death induction and sensitization to chemotherapeutic drugs in lung cancer. Phytotherapy Research 2019;33:2531-47. [DOI: 10.1002/ptr.6422] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
52 Xing F, Sun C, Luo N, He Y, Chen M, Ding S, Liu C, Feng L, Cheng Z. Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway. Med Sci Monit 2019;25:6007-14. [PMID: 31402794 DOI: 10.12659/MSM.913829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Wang L, Dong Y, Zhang Y, Zhang Z, Chi K, Yuan H, Zhao A, Ren J, Xiao F, Wang S. PtAu alloy nanoflowers on 3D porous ionic liquid functionalized graphene-wrapped activated carbon fiber as a flexible microelectrode for near-cell detection of cancer. NPG Asia Mater 2016;8:e337-e337. [DOI: 10.1038/am.2016.189] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
54 Xu T, Guo P, He Y, Pi C, Wang Y, Feng X, Hou Y, Jiang Q, Zhao L, Wei Y. Application of curcumin and its derivatives in tumor multidrug resistance. Phytother Res 2020;34:2438-58. [PMID: 32255545 DOI: 10.1002/ptr.6694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Lee T, Seo E, Lee J, Jun JH. Synergistic Anticancer Effects of Curcumin and Hinokitiol on Gefitinib Resistant Non-Small Cell Lung Cancer Cells. Natural Product Communications 2018;13:1934578X1801301. [DOI: 10.1177/1934578x1801301223] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
56 Haider M, Elsherbeny A, Pittalà V, Consoli V, Alghamdi MA, Hussain Z, Khoder G, Greish K. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer. IJMS 2022;23:1853. [DOI: 10.3390/ijms23031853] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Smagurauskaite G, Mahale J, Brown K, Thomas AL, Howells LM. New Paradigms to Assess Consequences of Long-Term, Low-Dose Curcumin Exposure in Lung Cancer Cells. Molecules 2020;25:E366. [PMID: 31963196 DOI: 10.3390/molecules25020366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
58 Kong WY, Ngai SC, Goh BH, Lee LH, Htar TT, Chuah LH. Is Curcumin the Answer to Future Chemotherapy Cocktail? Molecules 2021;26:4329. [PMID: 34299604 DOI: 10.3390/molecules26144329] [Reference Citation Analysis]
59 Khatoon E, Banik K, Harsha C, Sailo BL, Thakur KK, Khwairakpam AD, Vikkurthi R, Devi TB, Gupta SC, Kunnumakkara AB. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.06.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]